Male Reproductive Disorders, Diseases, and Costs of Exposure to Endocrine-Disrupting Chemicals in the European Union



: Hauser R, Skakkebaek NE, Hass U, Toppari J, Juul A, Andersson AM, Kortenkamp A, Heindel JJ, Trasande L

Publisher: ENDOCRINE SOC

: 2015

: Journal of Clinical Endocrinology and Metabolism

: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

: J CLIN ENDOCR METAB

: 100

: 4

: 1267

: 1277

: 11

: 0021-972X

: 1945-7197

DOI: https://doi.org/10.1210/jc.2014-4325


Conclusions: EDCs may contribute substantially to male reproductive disorders and diseases, with nearly (sic)15 billion annual associated costs in the EU. These estimates represent only a few EDCs for which there were sufficient epidemiological studies and those with the highest probability of causation. These public health costs should be considered as the EU contemplates regulatory action on EDCs.




Last updated on 2024-26-11 at 22:43